Feedback / Questions
ILKN421H - iLeukon Therapeutics
https://www.prnewswire.com/news-releases/ileukon-receives-fda-clearance-of-ind-application-for-a-phase-ii-study-of-mrna-based-non-alpha-il-2-variant-ilkn421h-in-advanced-non-small-cell-lung-cancer-nsclc-302603529.html
Nov 4, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next